Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Collegium Pharmaceutical, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
COLL
Nasdaq
2830
www.collegiumpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference
- Apr 15th, 2026 7:01 pm
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
- Apr 14th, 2026 4:46 am
How The Collegium Pharmaceutical (COLL) Narrative Is Evolving On A Modest Target Price Shift
- Apr 11th, 2026 8:11 pm
3 Cash-Producing Stocks Walking a Fine Line
- Apr 10th, 2026 10:22 am
Collegium to Participate in Upcoming Investor Conferences
- Apr 8th, 2026 6:00 am
1 Value Stock on Our Buy List and 2 Facing Headwinds
- Apr 6th, 2026 4:27 am
GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know
- Apr 2nd, 2026 6:16 pm
2 Profitable Stocks to Consider Right Now and 1 We Question
- Apr 2nd, 2026 6:40 am
Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers
- Mar 31st, 2026 5:34 am
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD
- Mar 30th, 2026 7:32 pm
Collegium’s AZSTARYS Deal And Insider Sale Put Focus On Valuation
- Mar 27th, 2026 4:07 am
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
- Mar 26th, 2026 2:35 am
Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million
- Mar 25th, 2026 8:19 am
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037
- Mar 19th, 2026 7:51 am
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
- Mar 19th, 2026 6:00 am
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know
- Mar 16th, 2026 7:27 pm
Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference
- Mar 14th, 2026 12:02 pm
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure
- Mar 13th, 2026 7:14 pm
3 Healthcare Stocks Walking a Fine Line
- Mar 13th, 2026 3:46 am
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results
- Mar 10th, 2026 7:04 am
Scroll